Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia

Stock Information for Eyenovia Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Eyenovia Inc.

Eyenovia Enrolls First Patient in Phase III CHAPERONE Study for Progressive Myopia
Eyenovia Reports First Quarter 2019 Financial Results
Eyenovia Announces Presentation of Successful Phase 3 Studies at the ASCRS-ASOA Annual Meeting
Eyenovia Announces Conference Call and Webcast for First Quarter 2019 Financial Results
Eyenovia Reports Fourth Quarter and Full Year 2018 Financial Results
Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial Results
Eyenovia to Participate in Two Upcoming Investor Conferences
Eyenovia Announces Confirmatory Results from Second MicroStat Phase III Registration Study for Mydriasis

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.